Advanced Therapy Medicinal Products

Advanced Therapy Medicinal Products

Global Advanced Therapy Medicinal Products Market to Reach $24 Billion by 2030
The global market for Advanced Therapy Medicinal Products estimated at US$9.7 Billion in the year 2022, is expected to reach US$24 Billion by 2030, growing at a CAGR of 12% over the period 2022-2030. Tissue Engineered Products, one of the segments analyzed in the report, is expected to record 12.7% CAGR and reach US$10 Billion by the end of the analysis period. Growth in the Cell Therapy segment is estimated at 11.3% CAGR for the next 8-year period.

The U.S. Market is Estimated at $4.3 Billion, While China is Forecast to Grow at 10.4% CAGR
The Advanced Therapy Medicinal Products market in the U.S. is estimated at US$4.3 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.1 Billion by the year 2030 trailing a CAGR of 10.4% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10% and 8.9% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 13.1% CAGR.

What to Expect from the Global Economy in 2024
Edgy geopolitics, and economic instability caused by monetary policy tightening and ensuing higher interest rates will create a tumultuous landscape for 2024. Several factors will continue to exert pressure on the path to recovery including hostilities in the Middle East and increasingly common climate disasters. Among the risks, several positives are also taking shape such as growing signs of disinflation and easing of anxiety over stubborn inflation, supply chain normalization and price moderation despite volatility in energy costs. Elections across several G21 jurisdictions, notably in India and the United States, will have potential ramifications for capital flows and investment strategies. While India emerges as a compelling destination in the global investment landscape, U.S, based tech firms will continue to dominate, fueled by a dynamic ecosystem of talent and capital. Tech opportunities in Silicon Valley and beyond remain attractive for investors seeking high-growth prospects supported largely by a resilient albeit slowing domestic economy and conducive regulatory environment. Europe will continue to battle tight monetary policy and recession risks with U.K. having the most challenging outlook and running the greatest risk of recession in 2024. China remains a wild card with hope for growth in the country underpinned by government spending and improvements in consumer spending. The volatile environment will offer both opportunities and challenges for investors and businesses alike. Embracing volatility as a catalyst for growth together with agility and strategic foresight in navigating investment decisions will remain important for survival.

Select Competitors (Total 190 Featured) -
  • Bluebird Bio Inc.
  • Bristol-Myers Squibb Company
  • F. Hoffmann-La Roche Ltd.
  • Gilead Sciences, Inc.
  • JCR Pharmaceuticals Co. Ltd.
  • Kolon TissueGene, Inc.
  • MEDIPOST Co., Ltd.
  • Novartis AG
  • Organogenesis Inc.
  • Spark Therapeutics, Inc.
  • UniQure N.V.
  • Vericel Corporation
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
A Prelude to Advanced Therapy Medicinal Products (ATMP)
ATMPs' Costs and Availability
Global Economic Outlook
Global Market Prospects and Outlook
Advanced Therapy Medicinal Products Market Poised to Witness Rapid Growth
Growth Drivers and Challenges
ATMP Marketing Authorisations: An Insight
North America and Europe Dominate, Asia-Pacific to Exhibit Fastest Growth
Competition
Recent Market Activity
Advanced Therapy Medicinal Products - Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rising Geriatric Population and Subsequent Growth in Prevalence of Neurological Disorders Drive Market Demand
Global Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
Regenerative Medicine: A Promising Area for Advanced Therapy Medicinal Products
Global Regenerative Medicine Market Size in US$ Billion for 2019, 2021, 2023 and 2025
Global Regenerative Medicines Market by Category: Breakdown (in %) for Biomaterials, Stem Cell Therapies and Tissue Engineering for 2022
Stem Cell Therapy: A Promising Avenue for Nerve Repair and Regeneration
Rising Demand for Gene Therapy Spurs Market Expansion
List of Genetic Disorders by Event, Genetic Manifestation and Prevalence
Top Ten Genetic Diseases Worldwide
Oncology Represents the Largest Indication for Gene Therapy
Uptrend in Healthcare Spending Creates Fertile Environment
World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
Expanding Role of Advanced Therapy Medicinal Products Market in Personalized Medicine
Global Personalized Medicine Market: Revenues in US$ Million for the Years 2019, 2021, 2023 and 2025
World Personalized Medicine Market by Region/Country (2022): Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific and Rest of World
Biotech Research Spending Patterns Steer Momentum
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Advanced Therapy Medicinal Products Market Analysis of Annual Sales in US$ Million for Years 2022 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Advanced Therapy Medicinal Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 3: World 7-Year Perspective for Advanced Therapy Medicinal Products by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
TABLE 4: World Recent Past, Current & Future Analysis for Tissue Engineered Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 5: World 7-Year Perspective for Tissue Engineered Products by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
TABLE 6: World Recent Past, Current & Future Analysis for Cell Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 7: World 7-Year Perspective for Cell Therapy by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Gene Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 9: World 7-Year Perspective for Gene Therapy by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
TABLE 10: World Recent Past, Current & Future Analysis for CAR-T Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 11: World 7-Year Perspective for CAR-T Therapy by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
Advanced Therapy Medicinal Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 12: USA Recent Past, Current & Future Analysis for Advanced Therapy Medicinal Products by Type - Tissue Engineered Products, Cell Therapy, Gene Therapy and CAR-T Therapy - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 13: USA 7-Year Perspective for Advanced Therapy Medicinal Products by Type - Percentage Breakdown of Value Revenues for Tissue Engineered Products, Cell Therapy, Gene Therapy and CAR-T Therapy for the Years 2024 & 2030
CANADA
TABLE 14: Canada Recent Past, Current & Future Analysis for Advanced Therapy Medicinal Products by Type - Tissue Engineered Products, Cell Therapy, Gene Therapy and CAR-T Therapy - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 15: Canada 7-Year Perspective for Advanced Therapy Medicinal Products by Type - Percentage Breakdown of Value Revenues for Tissue Engineered Products, Cell Therapy, Gene Therapy and CAR-T Therapy for the Years 2024 & 2030
JAPAN
Advanced Therapy Medicinal Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 16: Japan Recent Past, Current & Future Analysis for Advanced Therapy Medicinal Products by Type - Tissue Engineered Products, Cell Therapy, Gene Therapy and CAR-T Therapy - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 17: Japan 7-Year Perspective for Advanced Therapy Medicinal Products by Type - Percentage Breakdown of Value Revenues for Tissue Engineered Products, Cell Therapy, Gene Therapy and CAR-T Therapy for the Years 2024 & 2030
CHINA
Advanced Therapy Medicinal Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 18: China Recent Past, Current & Future Analysis for Advanced Therapy Medicinal Products by Type - Tissue Engineered Products, Cell Therapy, Gene Therapy and CAR-T Therapy - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 19: China 7-Year Perspective for Advanced Therapy Medicinal Products by Type - Percentage Breakdown of Value Revenues for Tissue Engineered Products, Cell Therapy, Gene Therapy and CAR-T Therapy for the Years 2024 & 2030
EUROPE
Advanced Therapy Medicinal Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 20: Europe Recent Past, Current & Future Analysis for Advanced Therapy Medicinal Products by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 21: Europe 7-Year Perspective for Advanced Therapy Medicinal Products by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
TABLE 22: Europe Recent Past, Current & Future Analysis for Advanced Therapy Medicinal Products by Type - Tissue Engineered Products, Cell Therapy, Gene Therapy and CAR-T Therapy - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 23: Europe 7-Year Perspective for Advanced Therapy Medicinal Products by Type - Percentage Breakdown of Value Revenues for Tissue Engineered Products, Cell Therapy, Gene Therapy and CAR-T Therapy for the Years 2024 & 2030
FRANCE
Advanced Therapy Medicinal Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 24: France Recent Past, Current & Future Analysis for Advanced Therapy Medicinal Products by Type - Tissue Engineered Products, Cell Therapy, Gene Therapy and CAR-T Therapy - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 25: France 7-Year Perspective for Advanced Therapy Medicinal Products by Type - Percentage Breakdown of Value Revenues for Tissue Engineered Products, Cell Therapy, Gene Therapy and CAR-T Therapy for the Years 2024 & 2030
GERMANY
Advanced Therapy Medicinal Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 26: Germany Recent Past, Current & Future Analysis for Advanced Therapy Medicinal Products by Type - Tissue Engineered Products, Cell Therapy, Gene Therapy and CAR-T Therapy - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 27: Germany 7-Year Perspective for Advanced Therapy Medicinal Products by Type - Percentage Breakdown of Value Revenues for Tissue Engineered Products, Cell Therapy, Gene Therapy and CAR-T Therapy for the Years 2024 & 2030
ITALY
TABLE 28: Italy Recent Past, Current & Future Analysis for Advanced Therapy Medicinal Products by Type - Tissue Engineered Products, Cell Therapy, Gene Therapy and CAR-T Therapy - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 29: Italy 7-Year Perspective for Advanced Therapy Medicinal Products by Type - Percentage Breakdown of Value Revenues for Tissue Engineered Products, Cell Therapy, Gene Therapy and CAR-T Therapy for the Years 2024 & 2030
UNITED KINGDOM
Advanced Therapy Medicinal Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 30: UK Recent Past, Current & Future Analysis for Advanced Therapy Medicinal Products by Type - Tissue Engineered Products, Cell Therapy, Gene Therapy and CAR-T Therapy - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 31: UK 7-Year Perspective for Advanced Therapy Medicinal Products by Type - Percentage Breakdown of Value Revenues for Tissue Engineered Products, Cell Therapy, Gene Therapy and CAR-T Therapy for the Years 2024 & 2030
REST OF EUROPE
TABLE 32: Rest of Europe Recent Past, Current & Future Analysis for Advanced Therapy Medicinal Products by Type - Tissue Engineered Products, Cell Therapy, Gene Therapy and CAR-T Therapy - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 33: Rest of Europe 7-Year Perspective for Advanced Therapy Medicinal Products by Type - Percentage Breakdown of Value Revenues for Tissue Engineered Products, Cell Therapy, Gene Therapy and CAR-T Therapy for the Years 2024 & 2030
ASIA-PACIFIC
Advanced Therapy Medicinal Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 34: Asia-Pacific Recent Past, Current & Future Analysis for Advanced Therapy Medicinal Products by Type - Tissue Engineered Products, Cell Therapy, Gene Therapy and CAR-T Therapy - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 35: Asia-Pacific 7-Year Perspective for Advanced Therapy Medicinal Products by Type - Percentage Breakdown of Value Revenues for Tissue Engineered Products, Cell Therapy, Gene Therapy and CAR-T Therapy for the Years 2024 & 2030
REST OF WORLD
TABLE 36: Rest of World Recent Past, Current & Future Analysis for Advanced Therapy Medicinal Products by Type - Tissue Engineered Products, Cell Therapy, Gene Therapy and CAR-T Therapy - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 37: Rest of World 7-Year Perspective for Advanced Therapy Medicinal Products by Type - Percentage Breakdown of Value Revenues for Tissue Engineered Products, Cell Therapy, Gene Therapy and CAR-T Therapy for the Years 2024 & 2030
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings